The cause of lupus erythematosus is not known, but research suggests that it is related to genes, ultraviolet light, drugs, infection and oestrogen.
The results of a new study recently showed that Olutasidenib monotherapy in patients with relapsed/refractory acute myeloid leukaemia carrying the IDH1 mutation elicited high rates of complete remission with manageable toxicity.